InvestorsHub Logo
Followers 12
Posts 672
Boards Moderated 0
Alias Born 07/25/2007

Re: Johnnycash2013 post# 464

Wednesday, 01/27/2016 10:47:47 AM

Wednesday, January 27, 2016 10:47:47 AM

Post# of 6939
The deal between Albumedix and Eleven Biotherapeutics was completed on 4 December 2015. The terms of the agreement are not disclosed but under the agreement, Albumedix will pay Eleven an upfront fee as well as a share of commercialisation income.
Things look a bit rough here, but that sounds like a lump sum of cash and a future revenue stream. I guess it depends what Albumedix does with it.